Clinical Trial Design & Strategy Consulting
Protocol Development, Feasibility & Regulatory-Aligned Study Planning
BioBoston Consulting provides clinical trial design consulting for biotech and pharma. We support protocol development, feasibility, and regulatory-aligned study strategy to generate interpretable evidence and support regulatory decisions. Related support includes biostatistics consulting services.
Senior clinical strategy and trial design expertise
Feasibility-focused protocols that reduce delays
Aligned to regulatory expectations and best practices
Supports early-stage through pivotal studies
START A CONVERSATION
Tell Us What Support You Need
Select the support you need and share a few details about your project. We’ll use this information to route your inquiry to the appropriate BioBoston Consulting team member.
Who this is for
This service is a fit if
- You’re planning a first-in-human or early-phase trial and need a clear strategy
- Your protocol is getting stuck internally or with external stakeholders
- You want endpoints, population, and design choices that regulators will accept
- You’re concerned about feasibility, enrollment, timelines, or budget
- You need an experienced partner to pressure-test assumptions before you commit
What you’ll get
- You will receive practical trial design outputs such as:
- Clinical development strategy and trial design recommendations
- A protocol draft or optimized protocol with clear rationale for key choices
- Endpoint strategy (primary/secondary, definitions, and alignment to objectives)
- Patient population and inclusion/exclusion refinement to improve feasibility
- Enrollment and retention strategy considerations to reduce delays
- Statistical analysis planning inputs aligned to your design and objectives
- Regulatory-ready planning support (document strategy and meeting preparation as needed)
What we do
Our Clinical Trial Design and Strategy support can include:
- Protocol development and optimization
- Patient recruitment and retention strategy support
- Endpoint selection and validation planning
- Statistical analysis planning support (in partnership with biostatistics as needed)
- Trial feasibility and operational strategy inputs (sites, timelines, risk points)
- Regulatory submission support for trial strategy and documentation
- Trial monitoring and oversight planning (governance, KPIs, risk-based approach)
Why BioBoston
- A strong trial design balances science, feasibility, and regulatory expectations
- We help you avoid the common pitfalls: over-complex protocols, unrealistic enrollment assumptions, endpoints that don’t support claims, and late-stage rework. You get a clear strategy, clean documentation, and a design your team can execute
Strategy + design plan
We define the recommended design approach, key decisions, and deliverables
Draft + refine
We develop or optimize protocol and strategy content with clear rationale and practical execution guidance
Discovery call
We confirm your therapy area, target indication, program stage, and goals
How it works
Frequently Asked Questions
Can you support both early-phase and late-stage trial design?
Yes. We tailor the strategy and protocol approach to your stage and evidence needs.
Do you support regulatory interaction planning as part of design work?
Yes. We can support the strategy and documentation needed for regulatory discussions.
Can you align trial design with operational realities?
Yes. Feasibility and execution risk reduction are core parts of our approach.